EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Repressing IRS1 /2 by NT157 inhibits the malignant behaviors of ovarian cancer through inactivating PI3K / AKT / mTOR pathway and inducing autophagy

Cai-Xia Li, Chuan-Di Men, Wei-Hong Yang, Rong Chen, Ji-Hui Zhu, Zhong-Ping Cheng iD

The Kaohsiung Journal of Medical Sciences · 2023

DOI: 10.1002/kjm2.12652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2023. Verfasst von Cai-Xia Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, Shanghai Tenth People's Hospital Affiliated to Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin receptor substrate 1 and 2 (IRS1/2) have been found involved in many cancers development and their inhibitors exert significant tumor‐suppressive effects. Here, we tried to explore the function of NT157, an IGF1R‐IRS1/2 inhibitor, in ovarian cancer. We treated ovarian cancer cells with varying doses of NT157. The MTT assay was employed to evaluate cell proliferation and colony formation assay was used for detecting colony‐forming ability. TUNEL assay was adopted to test cell apoptosis. Cell invasion was checked by the Transwell assay. The expression of apoptosis‐related proteins, autophagy markers, IRS1/2, and PI3K/AKT/mTOR pathway was compared by Western blot, immunofluorescence, or qRT‐PCR. As indicated by the data, NT157 abated the viability, proliferation, and induced autophagy of ovarian cancer cells. Overexpressing IRS1/2 attenuated the tumor‐suppressive effect of NT157 and heightened the PI3K/AKT/mTOR pathway activation. Inhibition of the PI3K/AKT/mTOR pathway enhanced the tumor‐suppressive effect of NT157 and facilitated NT157‐mediated autophagy. However, the autophagy inhibitor 3‐MA partly reversed NT‐157‐mediated antitumor effects. In conclusion, this study disclosed that NT157 suppressed the malignant phenotypes of ovarian cancer cells by inducing autophagy and hampering the expression of IRS1/2 and PI3K/AKT/mTOR pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsProto-Oncogene Proteins c-aktFemaleHumansApoptosisAutophagyCell Line, TumorCell ProliferationInsulin Receptor Substrate ProteinsPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsSignal TransductionTOR Serine-Threonine KinasesPyrogallolSulfonamides

Stichwörter der Autor:innen

IRS1/2NT157autophagyovarian cancer

Substanzen

Insulin Receptor Substrate ProteinsPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesIRS1 protein, humanMTOR protein, humanNT157 compoundPyrogallolSulfonamides

Autor:innen und Institutionen

  • Department of Gynaecology and Obstetrics, Shanghai Tenth People's Hospital Affiliated to Tongji University, Shanghai, China.

ORCID-Profile: Zhong-Ping Cheng

Förderung

  • The Fundamental Research Funds for the Central Universities

Zitieren

APA

Li, C. X., Men, C. D., Yang, W. H., Chen, R., Zhu, J. H., & Cheng, Z. P. (2023). Repressing IRS1 /2 by NT157 inhibits the malignant behaviors of ovarian cancer through inactivating PI3K / AKT / mTOR pathway and inducing autophagy. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.12652

Vancouver

Li CX, Men CD, Yang WH, Chen R, Zhu JH, Cheng ZP. Repressing IRS1 /2 by NT157 inhibits the malignant behaviors of ovarian cancer through inactivating PI3K / AKT / mTOR pathway and inducing autophagy. The Kaohsiung Journal of Medical Sciences. 2023. doi:10.1002/kjm2.12652

BibTeX
@article{Li2023,
  author = {Li, Cai-Xia and Men, Chuan-Di and Yang, Wei-Hong and Chen, Rong and Zhu, Ji-Hui and Cheng, Zhong-Ping},
  title = {Repressing IRS1 /2 by NT157 inhibits the malignant behaviors of ovarian cancer through inactivating PI3K / AKT / mTOR pathway and inducing autophagy},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2023},
  doi = {10.1002/kjm2.12652}
}
Kostenlos starten →